Dow Corning makes breast implant settlement offer:
This article was originally published in Clinica
Executive Summary
Women with silicone breast implant claims have 60 days to decide whether or not to accept Dow Corning's proposed $3.2 billion settlement, details of which they have received in the post. The proposed plan, which was approved last November by the company and a committee representing the claimants, could result in women receiving between $2,000 and $250,000, or choosing to litigate their claims (see Clinica No 834, p 12). The plan is also designed to resolve Dow Corning's chapter 11 bankruptcy.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.